The Generation Study is offering new mothers clarity through large-scale genomic screening, as

The Generation Study is offering new mothers clarity through large-scale genomic screening, as demonstrated by thirty-two-year-old Anisa Iqbal from Bradford, who reported a comforting sense of security after her newborn son, Kiyaan, received clear genetic test results for over two hundred rare conditions.

Generation Study Identifies over 200 Rare Genetic Conditions

  • Genomic Screening: The Generation Study identifies over 200 rare genetic conditions in newborn babies.

Anisa Iqbal Participates in The Generation Study

Anisa Iqbal enrolled in The Generation Study during an antenatal class prior to giving birth to her son, Kiyaan. The thirty-two-year-old Bradford resident lives with muscular dystrophy, a genetic disability she did not discover until her teenage years. That personal diagnostic journey motivated her to participate in the genomic initiative.

There are so many conditions you probably haven’t even heard of or are aware of that they can test for, and it can be picked up very early on rather than finding out about it later on, Iqbal said. It’s a sense of security and knowing that the tests have been done.

Genomic Analysis Confirms Kiyaan Has Clear Screening Results

Kiyaan’s birth followed a complicated clinical timeline. Iqbal contracted sepsis when her waters broke at thirty-five weeks. That infection required a month-long hospital admission leading up to labor, during which she experienced a fourth-degree tear.

Despite those acute obstetric challenges, genomic analysis of the newborn sample confirmed that Kiyaan’s screening results for the targeted panel of rare conditions were clear.

Study Parameter Clinical Metric
Target Participant Cohort 1,500 women
Target Condition Volume Over 200 rare genetic conditions

References

  • BBC News.
Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Jacobo Ramon positioned as ideal long-term successor for Liverpool